NCT02920372View on ClinicalTrials.gov

Generation of Positive Biological Samples to Epoetin for Doping Control.

PHASE1CompletedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

January 17, 2017

Study Completion Date

September 30, 2017

Conditions
There Are no Conditions Under Study. Healthy Volunteers
Interventions
DRUG

EPOETIN ALFA

All Listed Sponsors
lead

Parc de Salut Mar

OTHER

NCT02920372 - Generation of Positive Biological Samples to Epoetin for Doping Control. | Biotech Hunter | Biotech Hunter